Red blood cell alloantibodies in transfused patients with haematological malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute: Prevalence, specificities and associated factors

Documenti analoghi

• Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study
  di: Guillaume Simoens, et al.
  Pubblicazione: (2025)
• Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada
  di: S. Hutspardol, et al.
  Pubblicazione: (2026)
• Multinational transfusion practices and outcomes in haematology patients admitted to the intensive care unit
  di: Caroline M. Schaap, et al.
  Pubblicazione: (2025)
• Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting
  di: Jessie S. Luken, et al.
  Pubblicazione: (2026)
• Cross‐sectional survey of the barriers and enablers to preventing iatrogenic anaemia in inpatients with haematological malignancies: The CONSERVE study
  di: Courtney Black, et al.
  Pubblicazione: (2026)